Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides ""passive"" immunity to the patient against an agent. This is in contrast to vaccines that provide ""active"" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant ""passive"" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The global Hyperimmune Globulins market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Hyperimmune Globulins by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Hepatitis B Immunoglobulins
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Sichuan Yuanda Shuyang
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)